← Back to Analyst Consensus 
OFIX Buy
Orthofix Medical Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 10, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 6, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| May 22, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 22, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| May 22, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Apr 10, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Mar 9, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Feb 26, 2026 | Canaccord Genuity | maintain | Buy → Buy | $20 | 48% |
| Feb 25, 2026 | Barrington Research | maintain | Outperform → Outperform | $17 | 56% |
| Feb 17, 2026 | Barrington Research | maintain | Outperform → Outperform | $18 | 56% |
| Jan 27, 2026 | TD Cowen | initiate | — → Hold | $14 | 54% |
| Nov 5, 2025 | Barrington Research | maintain | Outperform → Outperform | $18 | 56% |
| Oct 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $17 | 56% |
| Sep 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $17 | 56% |
| Jun 23, 2025 | Barrington Research | initiate | — → Outperform | $16 | 56% |
| Jun 6, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Feb 26, 2025 | Canaccord Genuity | maintain | Buy → Buy | $24 | 48% |
| Feb 26, 2025 | Roth MKM | reiterate | Buy → Buy | $22 | 52% |
| Jan 22, 2025 | Canaccord Genuity | initiate | — → Buy | $24 | 48% |
| Nov 8, 2024 | Roth MKM | reiterate | Buy → Buy | $22 | 52% |
| Nov 8, 2024 | Stifel | upgrade | Hold → Buy | $24 | 53% |
| May 8, 2024 | Roth MKM | upgrade | Neutral → Buy | $20 | 52% |
| Apr 22, 2024 | JMP Securities | reiterate | — → Market Perform | $0 | 53% |
| Mar 7, 2024 | Roth MKM | maintain | Neutral → Neutral | $15 | 52% |
| Oct 20, 2023 | Roth MKM | initiate | — → Neutral | $12 | 52% |
| Sep 12, 2023 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Sep 12, 2023 | Stifel | downgrade | Buy → Hold | $16 | 53% |
| Mar 4, 2022 | Stifel | upgrade | Hold → Buy | $45 | 53% |
| Oct 20, 2020 | Stifel | initiate | — → Hold | $39 | 53% |
| Feb 25, 2020 | Sidoti & Co. | maintain | — → Buy | $56 | 38% |
| Feb 25, 2020 | Cantor Fitzgerald | maintain | — → Neutral | $42 | 50% |
| Oct 29, 2019 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $48 | 50% |
| Feb 26, 2019 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Jun 1, 2018 | Cantor Fitzgerald | initiate | — → Overweight | $62 | 50% |
| Jun 21, 2017 | BTIG | initiate | — → Buy | $52 | 52% |
| Jun 14, 2017 | Ladenburg Thalmann | initiate | — → Buy | $53.25 | 45% |
| May 23, 2017 | SunTrust Robinson Humphrey | initiate | — → Buy | $49 | — |
| May 9, 2013 | JMP Securities | downgrade | Market Outperform → Market Perform | $0 | 53% |
| May 9, 2013 | Mizuho | downgrade | Buy → Neutral | $28 | 52% |
| May 9, 2013 | Janney Montgomery Scott | downgrade | Buy → Neutral | $30 | 55% |
| May 9, 2013 | Lazard | downgrade | Buy → Sell | $0 | — |
| Feb 25, 2013 | Piper Sandler | maintain | — → Neutral | $43 | 54% |
| Jan 3, 2013 | Lazard | maintain | — → Buy | $44 | — |
| Oct 31, 2012 | Piper Sandler | maintain | — → Neutral | $47 | 54% |
Price Target Trend
Apr 9, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days